Answers are grounded in this paper and cite their sources.
Double fluorescence in situ hybridization was used to detect Philadelphia (Ph) chromosomes in interphase nuclei and metaphases of patients with chronic myeloid leukemia. Application of cosmid probes for 3' ABL and 5' BCR sequences gave better results than libraries for chromosomes 9 and 22. The present approach may provide an alternative method for monitoring minimal residual disease in Ph+ CML patients.
No takes yet. Share an insight, caveat, or question.
Arnoldus et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: